Tg Therapeutics (TGTX) Other Working Capital Changes (2012 - 2026)
Tg Therapeutics (TGTX) posted quarterly Other Working Capital Changes of -$424000.0 for Q1 2026, up 21.92% year-over-year from -$347782.5 in Q1 2025, and up 18.3% quarter-over-quarter from -$519000.0 in Q4 2025.
Tg Therapeutics (TGTX) Other Working Capital Changes (2012 - 2026) Analysis & Trends
Tg Therapeutics' Other Working Capital Changes history runs 5 years deep, the most recent figure standing at -$424000.0 for Q1 2026.
- In Q1 2026, Other Working Capital Changes rose 21.92% year-over-year to -$424000.0; the TTM figure through Mar 2026 stood at -$2.0 million (up 15.2% YoY), while the FY2025 annual figure was -$2.1 million, up 12.1% from the prior year.
- Other Working Capital Changes for Q1 2026 stood at -$424000.0, up from -$519000.0 in the prior quarter.
- The five-year high for Other Working Capital Changes was $38.6 million in Q3 2025, with the low at -$10.7 million in Q1 2026.
- The 5-year median for Other Working Capital Changes is -$38000.0 (2022), against an average of $2.6 million.
- The sharpest annual moves came in 2023 and 2026: Other Working Capital Changes decreased 0.68% in 2023, then increased 21.92% in 2026.
- Tg Therapeutics' Other Working Capital Changes stood at -$591000.0 in 2022, then retreated by 0.68% to -$595000.0 in 2023, then slipped by 0.5% to -$598000.0 in 2024, then increased by 13.21% to -$519000.0 in 2025, then gained by 18.3% to -$424000.0 in 2026.
- Business Quant data shows TGTX's Other Working Capital Changes at -$424000.0 in Q1 2026, -$519000.0 in Q4 2025, and -$519000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Tg Therapeutics | 7.46 Bn | 6.78 Bn | 199.14 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -13.57 Mn |
| Jun 30, 2026 | -13.57 Mn |
| Jun 30, 2026 | -13.57 Mn |
| Mar 31, 2026 | -10.66 Mn |
| Mar 31, 2026 | -10.66 Mn |
| Mar 31, 2026 | -10.66 Mn |
| Dec 31, 2025 | 1.91 Mn |
| Dec 31, 2025 | 1.91 Mn |
| Dec 31, 2025 | 1.91 Mn |
| Sep 30, 2025 | 38.59 Mn |
| Sep 30, 2025 | 38.59 Mn |
| Sep 30, 2025 | 38.59 Mn |
| Jun 30, 2025 | -2.70 Mn |
| Jun 30, 2025 | -2.70 Mn |
| Jun 30, 2025 | -2.70 Mn |
| Mar 31, 2025 | 4.63 Mn |
| Mar 31, 2025 | 4.63 Mn |
| Mar 31, 2025 | 4.63 Mn |
| Dec 31, 2024 | -1.76 Mn |
| Dec 31, 2024 | -1.76 Mn |